Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel potent NAMPT inhibitor reduces tumor growth in mouse model of TNBC

Jan. 8, 2020

New regeneration factor for muscle cells

Jan. 8, 2020

Lilly initiates phase I study of LY-3484356 in advanced or metastatic breast cancer

Jan. 7, 2020

Genentech begins phase II trial of BFKB-8488A in NASH

Jan. 7, 2020

TG-4050 enters first-in-human trials in head and neck cancer and ovarian cancer

Jan. 7, 2020

Oxurion reports phase I topline data on THR-687 for diabetic macular edema

Jan. 7, 2020

Mim8, an FVIII mimetic antibody, shows promise for hemophilia A

Jan. 7, 2020

Cytokinetics initiates phase II trial of CK-3773274 for hypertrophic cardiomyopathy

Jan. 7, 2020

MRx-0518 begins new trial in combination with radiotherapy for resectable pancreatic cancer

Jan. 7, 2020

Hepcidin mimetic PTG-300 begins phase II study in hereditary hemochromatosis

Jan. 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...